in past times several years, the united kingdom has witnessed a revolution in health care excess weight‑reduction treatment plans — through the introduction of semaglutide (Wegovy®) on the expanding level of popularity of tirzepatide (Mounjaro®). Now, Yet another name is drawing notice in equally